Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Overview of pathways that can be dysregulated by methamphetamine.

GR: glucocorticoid receptor, MR: mineralocorticoid receptor, 11β-HSD: 11β-hydroxysteroid dehydrogenase types 1 and 2, PXR: pregnane X receptor, MCP-1: Monocyte Chemoattractant Protein-1, SOD: Superoxide dismutase types 1 and 2, CYP: Cytochrome P450.

More »

Fig 1 Expand

Fig 2.

CYP probes.

Specific reactions used to determine CYP activity in the present study.

More »

Fig 2 Expand

Fig 3.

Methamphetamine plasma concentration (n = 4) vs time (hours) after third methamphetamine dose.

Test drugs caffeine (metabolised by CYP1A2) and midazolam (metabolised by CYP3A) was administered 2 hours after the methamphetamine dose and plasma samples were collected 3, 4, 5, 6 and 8 hours after methamphetamine dose. Error bars represent standard error of mean (SEM).

More »

Fig 3 Expand

Fig 4.

Normalised mRNA expression of hepatic drug metabolising enzyme CYP1A2 (A) between Control (n = 4) and MA (n = 4) groups. MNE, mean normalised expression; MA, methamphetamine; unpaired t test; *P<0.05 from Control.

More »

Fig 4 Expand

Fig 5.

Functional activity of hepatic CYP1A2 (A) and CYP3A (B) before (Pre-MA) and after (Post-MA) methamphetamine exposure (n = 4). MA, methamphetamine; AUC, area under the curve; paired t test; *P<0.05 from Pre-MA.

More »

Fig 5 Expand

Fig 6.

Normalised mRNA expression of hepatic drug transporters P-gp (A) and BCRP (B) between Control (n = 4) and MA (n = 4) groups. MNE, mean normalised expression; MA, methamphetamine; unpaired t test; *P<0.05 from Control.

More »

Fig 6 Expand

Fig 7.

Normalised mRNA expression of hepatic regulators of drug transporter and metabolising enzyme regulators MR (A), GR (B), 11βHSD1 (C), 11βHSD2 (D) and PXR (E) between Control (n = 4) and MA (n = 4) groups. MNE, mean normalised expression; MA, methamphetamine; unpaired t-test; *P<0.05 from Control.

More »

Fig 7 Expand

Fig 8.

Normalised mRNA expression of hepatic markers of inflammation p50 (A), p65 (B) and MCP1 (C) between Control (n = 4) and MA (n = 4) groups. MNE, mean normalised expression; MA, methamphetamine; unpaired t test; *P<0.05 from Control.

More »

Fig 8 Expand

Fig 9.

Normalised mRNA expression of hepatic SOD1 (A) and SOD2 (B) between Control (n = 4) and MA (n = 4) groups. MNE, mean normalised expression; MA, methamphetamine; unpaired t test; *P<0.05 from Control.

More »

Fig 9 Expand